0001209191-22-026089.txt : 20220428
0001209191-22-026089.hdr.sgml : 20220428
20220428194657
ACCESSION NUMBER: 0001209191-22-026089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220426
FILED AS OF DATE: 20220428
DATE AS OF CHANGE: 20220428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gross Jane A
CENTRAL INDEX KEY: 0001684258
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 22869332
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE, SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-26
0
0001339970
aTYR PHARMA INC
LIFE
0001684258
Gross Jane A
3545 JOHN HOPKINS COURT
SUITE 250
SAN DIEGO
CA
92121
1
0
0
0
Restricted Stock Units
2022-04-26
4
A
0
6000
0.00
A
Common Stock
6000
6000
D
Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
/s/ Nancy E. Denyes, as Attorney-in-Fact
2022-04-28